Romosozumab (EVENITY) is indicated for the treatment of osteoporosis in postmenopausal women at high risk of fracture (see Pharmacology: Pharmacodynamics: Clinical trials under Actions).
Treatment to increase bone mass in men with osteoporosis at high risk of fracture.